Items where Author is "Richardson-Harman, N"
Group by: Item Type | No Grouping Number of items: 3. Mcgowan, I and Cranston, RD and Duffill, K and Siegel, A and Engstrom, JC and Nikiforov, A and Jacobson, C and Rehman, KK and Elliott, J and Khanukhova, E and Abebe, K and Mauck, C and Spiegel, HML and Dezzutti, CS and Rohan, LC and Marzinke, MA and Hiruy, H and Hendrix, CW and Richardson-Harman, N and Anton, PA (2015) A phase 1 randomized, open label, rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of three formulations of tenofovir 1% Gel (the CHARM-01 study). PLoS ONE, 10 (5). Richardson-Harman, N and Hendrix, CW and Bumpus, NN and Mauck, C and Cranston, RD and Yang, K and Elliott, J and Tanner, K and McGowan, I and Kashuba, A and Anton, PA (2014) Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study. PLoS ONE, 9 (10). Yang, KH and Hendrix, C and Bumpus, N and Elliott, J and Tanner, K and Mauck, C and Cranston, R and McGowan, I and Richardson-Harman, N and Anton, PA and Kashuba, ADM (2014) A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate. PLoS ONE, 9 (10). |